An ISO-certified, multi-site clinical research organization with state-of-the-art facilities. Specializing in Phase 1b–3 trials across CNS, cardiometabolic, and immunology/dermatology, Progress delivers 3-month trial start-up, 95% on-time recruitment, and an 8.8 client satisfaction score.